FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4286542025> ?p ?o ?g. }

• W4286542025 endingPage "122" @default.
• W4286542025 startingPage "109" @default.
• W4286542025 abstract "Endometrial carcinoma is now considered a common female gynecologic cancer with increasing incidence, with 13-25% of patients being still liable to recurrence and metastasis, which needs further studies to detect novel targets and new therapies. The aim of the study was evaluate tissue expression of RON, ROR1 and SUSD2 in endometrial carcinoma and atypical endometrial hyperplasia using immunohistochemistry and correlate their expression with clinical, pathological and prognostic parameters of patients.We included samples from 100 patients with endometrial carcinoma. Sections from paraffin blocks were stained with RON, ROR1 and SUSD2 using immunohistochemistry. Correlations between marker expression, clinicopathological features and prognostic samples were evaluated.Upregulation of RON and ROR1 and downregulation of SUSD2 expression were found in endometrial carcinoma more than atypical endometrial hyperplasia (p < 0.001). High RON and ROR1 expression levels were significantly associated with high grade (p < 0.001), presence of lymph node metastases (p = 0.003), distant metastases (p = 0.009), advanced International Federation of Gynecology and Obstetrics stage (p = 0.002), poor response to therapy (p = 0.046), and lower recurrence-free survival (RFS) rate (p = 0.002), progression-free survival (PFS) rate (p = 0.008), distant metastasis-free survival (DMFS) rate (p = 0.019) and overall survival rate (p < 0.001). Low SUSD2 expression was significantly associated with older patient age (p = 0.002), large tumor size (p = 0.003), high grade (p = 0.005), presence of adnexal invasion (p = 0.023), presence of lympho-vascular invasion (p = 0.021), extent of myometrial invasion (p = 0.002), lower RFS rate (p = 0.008), lower PFS rate (p = 0.023), and lower DMFS rate (p < 0.001).Upregulation of RON and ROR1 and downregulation of SUSD2 lead to promotion of endometrial cancer cell proliferation, migration, epithelial-mesenchymal transition, and invasion." @default.
• W4286542025 created "2022-07-22" @default.
• W4286542025 creator A5024843057 @default.
• W4286542025 creator A5037004328 @default.
• W4286542025 creator A5037723727 @default.
• W4286542025 creator A5044453860 @default.
• W4286542025 creator A5045437696 @default.
• W4286542025 creator A5087138778 @default.
• W4286542025 creator A5090490127 @default.
• W4286542025 creator A5091002403 @default.
• W4286542025 date "2022-01-01" @default.
• W4286542025 modified "2023-10-18" @default.
• W4286542025 title "RON, ROR1 and SUSD2 expression in tissues of endometrial carcinoma patients. Clinicopathological and prognostic implications" @default.
• W4286542025 cites W1542053886 @default.
• W4286542025 cites W1785704905 @default.
• W4286542025 cites W1965498936 @default.
• W4286542025 cites W1983054966 @default.
• W4286542025 cites W2000269194 @default.
• W4286542025 cites W2030283269 @default.
• W4286542025 cites W2047311008 @default.
• W4286542025 cites W2075752480 @default.
• W4286542025 cites W2076188603 @default.
• W4286542025 cites W2089089047 @default.
• W4286542025 cites W2092864627 @default.
• W4286542025 cites W2104546896 @default.
• W4286542025 cites W2129875426 @default.
• W4286542025 cites W2137005750 @default.
• W4286542025 cites W2139647802 @default.
• W4286542025 cites W2142280045 @default.
• W4286542025 cites W2145132518 @default.
• W4286542025 cites W2154667395 @default.
• W4286542025 cites W2156013775 @default.
• W4286542025 cites W2160827892 @default.
• W4286542025 cites W2161817637 @default.
• W4286542025 cites W2162585517 @default.
• W4286542025 cites W2165200432 @default.
• W4286542025 cites W2205342039 @default.
• W4286542025 cites W2225004965 @default.
• W4286542025 cites W2260694511 @default.
• W4286542025 cites W2290720193 @default.
• W4286542025 cites W2534739696 @default.
• W4286542025 cites W2745805885 @default.
• W4286542025 cites W2765952964 @default.
• W4286542025 cites W2770576214 @default.
• W4286542025 cites W2782433211 @default.
• W4286542025 cites W2787147590 @default.
• W4286542025 cites W2806532541 @default.
• W4286542025 cites W2900902086 @default.
• W4286542025 cites W2954194137 @default.
• W4286542025 cites W2981524724 @default.
• W4286542025 cites W2983953361 @default.
• W4286542025 cites W3019693630 @default.
• W4286542025 cites W3031058158 @default.
• W4286542025 cites W3036331592 @default.
• W4286542025 cites W3049271086 @default.
• W4286542025 cites W3122500318 @default.
• W4286542025 cites W3205097499 @default.
• W4286542025 cites W62114904 @default.
• W4286542025 doi "https://doi.org/10.5114/wo.2022.118245" @default.
• W4286542025 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35903204" @default.
• W4286542025 hasPublicationYear "2022" @default.
• W4286542025 type Work @default.
• W4286542025 citedByCount "3" @default.
• W4286542025 countsByYear W42865420252023 @default.
• W4286542025 crossrefType "journal-article" @default.
• W4286542025 hasAuthorship W4286542025A5024843057 @default.
• W4286542025 hasAuthorship W4286542025A5037004328 @default.
• W4286542025 hasAuthorship W4286542025A5037723727 @default.
• W4286542025 hasAuthorship W4286542025A5044453860 @default.
• W4286542025 hasAuthorship W4286542025A5045437696 @default.
• W4286542025 hasAuthorship W4286542025A5087138778 @default.
• W4286542025 hasAuthorship W4286542025A5090490127 @default.
• W4286542025 hasAuthorship W4286542025A5091002403 @default.
• W4286542025 hasBestOaLocation W42865420251 @default.
• W4286542025 hasConcept C121608353 @default.
• W4286542025 hasConcept C126322002 @default.
• W4286542025 hasConcept C143998085 @default.
• W4286542025 hasConcept C193270364 @default.
• W4286542025 hasConcept C204232928 @default.
• W4286542025 hasConcept C207886595 @default.
• W4286542025 hasConcept C2775904963 @default.
• W4286542025 hasConcept C2776283816 @default.
• W4286542025 hasConcept C2777088508 @default.
• W4286542025 hasConcept C2777546739 @default.
• W4286542025 hasConcept C2779013556 @default.
• W4286542025 hasConcept C71924100 @default.
• W4286542025 hasConceptScore W4286542025C121608353 @default.
• W4286542025 hasConceptScore W4286542025C126322002 @default.
• W4286542025 hasConceptScore W4286542025C143998085 @default.
• W4286542025 hasConceptScore W4286542025C193270364 @default.
• W4286542025 hasConceptScore W4286542025C204232928 @default.
• W4286542025 hasConceptScore W4286542025C207886595 @default.
• W4286542025 hasConceptScore W4286542025C2775904963 @default.
• W4286542025 hasConceptScore W4286542025C2776283816 @default.
• W4286542025 hasConceptScore W4286542025C2777088508 @default.
• W4286542025 hasConceptScore W4286542025C2777546739 @default.
• W4286542025 hasConceptScore W4286542025C2779013556 @default.
• W4286542025 hasConceptScore W4286542025C71924100 @default.

• next